BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15123527)

  • 21. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
    Quaranta M; Daniele A; Coviello M; Venneri MT; Abbate I; Caringella ME; Di Tardo S; Divella R; Trerotoli P; Di Gennaro M; Schittulli F; Fransvea E; Giannelli G
    Anticancer Res; 2007; 27(5B):3593-600. PubMed ID: 17972522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone deficiency (GHD) in adult thalassaemic patients.
    Scacchi M; Danesi L; Cattaneo A; Valassi E; Pecori Giraldi F; Argento C; D'Angelo E; Mirra N; Carnelli V; Zanaboni L; Cappellini MD; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):790-5. PubMed ID: 17608814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning.
    Modanlou HD; Gharraee Z; Hasan J; Waltzman J; Nageotte S; Beharry KD
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):738-44. PubMed ID: 16431975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vascular endothelial growth factor and insulin-like-growth factors in prostate cancer. ].
    Trapeznikova MF; Shibaeva AN; Ianshin AA; Urenkov SB; Mironova OS; Kazantseva IA; Kushlinskiĭ NE
    Urologiia; 2004; (1):17-21. PubMed ID: 15022438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hemodiafiltration on pregnancy-associated plasma protein A (PAPP-A) and related parameters.
    Kalousová M; Hodková M; Dusilová-Sulková S; Uhrová J; Tesar V; Zima T
    Ren Fail; 2006; 28(8):715-21. PubMed ID: 17162432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
    Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selected matrix metalloproteinases (MMP-2, MMP-9) in obese children and adolescents].
    Głowińska-Olszewska B; Urban M; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):179-83. PubMed ID: 17020652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GH replacement reduces increased lipid peroxidation in GH-deficient adults.
    Karbownik-Lewinska M; Kokoszko A; Lewandowski KC; Shalet SM; Lewinski A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):957-64. PubMed ID: 18031310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in growth hormone and insulin-like growth factor-I levels in the acute stage after open heart surgery and at the time of discharge.
    Nakhjavani M; Esteghamati A; Hamidi S; Esfahanian F; Nabavi H; Abbasi M; Mirkhani SH
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):413-6. PubMed ID: 19609843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of serum levels of MMP-9 and VEGF in patients with bladder cancer].
    Guan KP; Hou SK; Yan Z; Ye HY
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):430-2. PubMed ID: 12895351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
    Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
    Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.
    Ishizaki E; Takai S; Ueki M; Maeno T; Maruichi M; Sugiyama T; Oku H; Ikeda T; Miyazaki M
    Am J Ophthalmol; 2006 Jan; 141(1):129-134. PubMed ID: 16386986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference.
    Soares DV; Conceição FL; Brasil RR; Spina LD; Lobo PM; Silva EM; Buescu A; Vaisman M
    Growth Horm IGF Res; 2004 Dec; 14(6):436-41. PubMed ID: 15519251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.